[go: up one dir, main page]

GB2453860B - Ionizing-radiation-responsive compositions,methods and systems - Google Patents

Ionizing-radiation-responsive compositions,methods and systems

Info

Publication number
GB2453860B
GB2453860B GB0818996A GB0818996A GB2453860B GB 2453860 B GB2453860 B GB 2453860B GB 0818996 A GB0818996 A GB 0818996A GB 0818996 A GB0818996 A GB 0818996A GB 2453860 B GB2453860 B GB 2453860B
Authority
GB
United Kingdom
Prior art keywords
ionizing
radiation
systems
methods
responsive compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB0818996A
Other versions
GB0818996D0 (en
GB2453860A (en
Inventor
Edward S Boyden
Roderick A Hyde
Muriel Y Ishikawa
Edward K Y Jung
Nathan P Myhrvold
Clarence T Tegreene
Thomas A Weaver
Charles Whitmer
Lowell L Wood Jr
Victoria Y H Wood
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Searete LLC
Original Assignee
Searete LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US11/975,702 external-priority patent/US8164074B2/en
Priority claimed from US12/012,217 external-priority patent/US9557635B2/en
Priority claimed from US12/012,220 external-priority patent/US8529426B2/en
Priority claimed from US12/012,229 external-priority patent/US8168958B2/en
Priority claimed from US12/012,209 external-priority patent/US8227204B2/en
Priority claimed from US12/012,233 external-priority patent/US20090104113A1/en
Priority claimed from US12/012,218 external-priority patent/US8684898B2/en
Application filed by Searete LLC filed Critical Searete LLC
Publication of GB0818996D0 publication Critical patent/GB0818996D0/en
Publication of GB2453860A publication Critical patent/GB2453860A/en
Publication of GB2453860B publication Critical patent/GB2453860B/en
Application granted granted Critical
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6921—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit the form being a particulate, a powder, an adsorbate, a bead or a sphere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0042—Photocleavage of drugs in vivo, e.g. cleavage of photolabile linkers in vivo by UV radiation for releasing the pharmacologically-active agent from the administered agent; photothrombosis or photoocclusion
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Radiation-Therapy Devices (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB0818996A 2007-10-18 2008-10-16 Ionizing-radiation-responsive compositions,methods and systems Expired - Fee Related GB2453860B (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US11/975,702 US8164074B2 (en) 2007-10-18 2007-10-18 Ionizing-radiation-responsive compositions, methods, and systems
US12/012,220 US8529426B2 (en) 2007-10-18 2008-01-30 Ionizing-radiation-responsive compositions, methods, and systems
US12/012,229 US8168958B2 (en) 2007-10-18 2008-01-30 Ionizing-radiation-responsive compositions, methods, and systems
US12/012,209 US8227204B2 (en) 2007-10-18 2008-01-30 Ionizing-radiation-responsive compositions, methods, and systems
US12/012,217 US9557635B2 (en) 2007-10-18 2008-01-30 Ionizing-radiation-responsive compositions, methods, and systems
US12/012,233 US20090104113A1 (en) 2007-10-18 2008-01-30 Ionizing-radiation-responsive compositions, methods, and systems
US12/012,218 US8684898B2 (en) 2007-10-18 2008-01-30 Ionizing-radiation-responsive compositions, methods, and systems

Publications (3)

Publication Number Publication Date
GB0818996D0 GB0818996D0 (en) 2008-11-26
GB2453860A GB2453860A (en) 2009-04-22
GB2453860B true GB2453860B (en) 2011-03-16

Family

ID=40097540

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0818996A Expired - Fee Related GB2453860B (en) 2007-10-18 2008-10-16 Ionizing-radiation-responsive compositions,methods and systems

Country Status (2)

Country Link
DE (1) DE102008052357A1 (en)
GB (1) GB2453860B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009015341A1 (en) * 2009-03-27 2010-10-07 Carl Zeiss Ag Method for optical testing of sample during e.g. chemical analysis, involves detecting optical emission of sample depending on characteristic modulation i.e. temporally periodic modulation, of particle beam
US9535016B2 (en) 2013-02-28 2017-01-03 William Beaumont Hospital Compton coincident volumetric imaging
DE102013209104A1 (en) 2013-05-16 2014-11-20 Carl Zeiss Microscopy Gmbh Apparatus and method for spectroscopic analysis
CN110559439A (en) * 2019-10-15 2019-12-13 上海纳米技术及应用国家工程研究中心有限公司 Preparation method of photo-thermal and photodynamic cooperative therapeutic agent

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773592A (en) * 1986-12-31 1998-06-30 Mills; Randell Lee Pro drugs for selective drug delivery
WO1999052565A1 (en) * 1998-04-13 1999-10-21 Light Sciences Limited Partnership Radionuclide excited phosphorescent material for administering pdt
WO2000036983A1 (en) * 1998-12-21 2000-06-29 Light Sciences Corporation Pegylated photosensitizers for abnormal tissue treatment
FR2820041A1 (en) * 2001-01-29 2002-08-02 Nero Didier Rege Product used to improve photodynamic treatment of cancers contains luminophore that emits red light under X-ray excitation
US20020127224A1 (en) * 2001-03-02 2002-09-12 James Chen Use of photoluminescent nanoparticles for photodynamic therapy
US20030191458A1 (en) * 2002-04-03 2003-10-09 Cornelius Diamond Light-activated drug delivery method and device
WO2005058360A2 (en) * 2003-12-17 2005-06-30 Philips Intellectual Property & Standards Gmbh Radiation therapy and medical imaging using uv emitting nanoparticles
US20070217996A1 (en) * 2004-05-10 2007-09-20 Laurent Levy Activatable Particles, Preparations and Uses
US20070218049A1 (en) * 2006-02-02 2007-09-20 Wei Chen Nanoparticle based photodynamic therapy and methods of making and using same
US20080193431A1 (en) * 2003-11-14 2008-08-14 University Of Pennsylvania Activatable photodynamic therapy agents

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6524274B1 (en) 1990-12-28 2003-02-25 Scimed Life Systems, Inc. Triggered release hydrogel drug delivery system
CA2107558A1 (en) 1992-03-04 1993-09-05 Nicholas Pomato In vivo binding pair pretargeting
US5482719A (en) 1992-10-30 1996-01-09 Guillet; James E. Drug delivery systems
US5470307A (en) 1994-03-16 1995-11-28 Lindall; Arnold W. Catheter system for controllably releasing a therapeutic agent at a remote tissue site
US5998580A (en) 1995-10-13 1999-12-07 Fay; Frederick F. Photosensitive caged macromolecules
JP2001501596A (en) 1996-08-27 2001-02-06 ユニバーシティ・オブ・ユタ・リサーチ・ファウンデーション Delivery of bioconjugates and biologically active agents
US6493570B1 (en) 1998-11-02 2002-12-10 Photogen, Inc. Method for improved imaging and photodynamic therapy
EP1007998A1 (en) 1997-02-11 2000-06-14 Massachusetts Institute Of Technology Polymeric photonic band gap materials
US6207392B1 (en) 1997-11-25 2001-03-27 The Regents Of The University Of California Semiconductor nanocrystal probes for biological applications and process for making and using such probes
AU4305101A (en) 1999-11-22 2001-06-04 Research Foundation Of The State University Of New York, The Magnetic nanoparticles for selective therapy
US6397102B1 (en) 2000-07-06 2002-05-28 Ceramoptec Industries, Inc. Device and method for photoactivated drug therapy
US6631283B2 (en) 2000-11-15 2003-10-07 Virginia Tech Intellectual Properties, Inc. B/B-like fragment targeting for the purposes of photodynamic therapy and medical imaging
US7067072B2 (en) 2001-08-17 2006-06-27 Nomadics, Inc. Nanophase luminescence particulate material
US20070117089A1 (en) 2005-11-21 2007-05-24 Croker Kevin M Sol-gel coated glass microspheres for use in bioassay

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5773592A (en) * 1986-12-31 1998-06-30 Mills; Randell Lee Pro drugs for selective drug delivery
WO1999052565A1 (en) * 1998-04-13 1999-10-21 Light Sciences Limited Partnership Radionuclide excited phosphorescent material for administering pdt
WO2000036983A1 (en) * 1998-12-21 2000-06-29 Light Sciences Corporation Pegylated photosensitizers for abnormal tissue treatment
FR2820041A1 (en) * 2001-01-29 2002-08-02 Nero Didier Rege Product used to improve photodynamic treatment of cancers contains luminophore that emits red light under X-ray excitation
US20020127224A1 (en) * 2001-03-02 2002-09-12 James Chen Use of photoluminescent nanoparticles for photodynamic therapy
US20030191458A1 (en) * 2002-04-03 2003-10-09 Cornelius Diamond Light-activated drug delivery method and device
US20080193431A1 (en) * 2003-11-14 2008-08-14 University Of Pennsylvania Activatable photodynamic therapy agents
WO2005058360A2 (en) * 2003-12-17 2005-06-30 Philips Intellectual Property & Standards Gmbh Radiation therapy and medical imaging using uv emitting nanoparticles
US20070217996A1 (en) * 2004-05-10 2007-09-20 Laurent Levy Activatable Particles, Preparations and Uses
US20070218049A1 (en) * 2006-02-02 2007-09-20 Wei Chen Nanoparticle based photodynamic therapy and methods of making and using same

Also Published As

Publication number Publication date
GB0818996D0 (en) 2008-11-26
GB2453860A (en) 2009-04-22
DE102008052357A1 (en) 2009-10-22

Similar Documents

Publication Publication Date Title
EP1986702A4 (en) Hyperpolarization methods, systems and compositions
ZA200906118B (en) Descenting systems and methods
IL220283A0 (en) 4-oxo-ih-quinoline-3- carboxamides, compositions comprising the same and uses thereof
IL241632B (en) Benzodiazepine derivatives, compositions comprising the same and uses thereof
IL201303A0 (en) Compositions, devices, systems, and methods for using a nanopore
ZA201001300B (en) Antigen-asjuvant compositions and methods
IL212836A0 (en) Azaquinolinone derivatives, compositions comprising the same and uses thereof
IL217541A0 (en) Triazolopyridine compounds, compositions comprising the same and uses thereof
IL212278A0 (en) Morpholinopurine derivatives, compositions comprising the same and uses thereof
ZA201005278B (en) Folates, compositions and uses thereof
EP2195328A4 (en) Certain chemical entities, compositions, and methods
EP2139478A4 (en) Certain chemical entities, compositions and methods
GB0706077D0 (en) Methods, Compositions and uses thereof
GB0601143D0 (en) Uses, methods and compositions
GB0721291D0 (en) Methods and compositions
IL213321A0 (en) Descenting systems and methods
IL219243A (en) 5-hydroxypyrimidine-4-carboxamide derivatives, compositions comprising the same and uses thereof
IL207639A0 (en) Pyrrolopyrimidinecarboxamide compounds, compositions comprising the same and uses thereof
GB0719592D0 (en) Compound, use and method
IL216828A0 (en) Styryl-triazine derivatives, compositions comprising the same and uses thereof
GB0725049D0 (en) Communiactions systems
GB0804897D0 (en) Messaging system
GB0719526D0 (en) Compositions and methods
AU2008284709B2 (en) Anti-hypertensive agent
GB2453860B (en) Ionizing-radiation-responsive compositions,methods and systems

Legal Events

Date Code Title Description
732E Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977)

Free format text: REGISTERED BETWEEN 20141120 AND 20141126

PCNP Patent ceased through non-payment of renewal fee

Effective date: 20171016